Medical device company Vertos Medical Inc.

Originally posted here:
Vertos Medical announces 12-week data from MiDAS I clinical study for lumbar spinal stenosis

Twelve-Week MiDAS I Clinical Study Data Confirm Safety, Efficacy of Vertos … Earthtimes Vertos Medical was founded to advance the treatment of patients suffering with lumbar spinal stenosis (LSS), a degenerative, age-related narrowing of the …

View post:
Twelve-Week MiDAS I Clinical Study Data Confirm Safety, Efficacy of Vertos … – Earthtimes

Medical device company Vertos Medical, Inc. has announced the release of additional patient outcomes data from the MiDAS I trial, a prospective, 75-patient study of mild for the treatment of lumbar spinal stenosis. As presented at the Florida Society of Interventional Pain Physicians Annual Meeting in Orlando on May 23, investigators found that study participants reported statistically significant improvement in both their physical and mental well-being six weeks following the mild procedure.

Originally posted here:
Data from MiDAS I trial of mild for treatment of LSS to be released

Medical device company Vertos Medical Inc. has announced the release of positive results from its U.S. IRB I Patient Outcomes Trial, a prospective, investigational review board-approved, 75-patient study of mild for the treatment of lumbar spinal stenosis (LSS).

Continued here:
Vertos Medical announces positive results from IRB I Patient Outcomes Trial of ‘mild’ for LSS

Medical device company Vertos Medical Inc. has reported that an observational study on mild*, published in the January/February 2010 issue of the peer-reviewed journal Pain Physician, has demonstrated the acute safety of the procedure in the treatment of lumbar spinal stenosis (LSS).1 The study, conducted by leading pain physicians Timothy Deer, M.D. (The Center for Pain Relief, Charleston, West …

Read the original here:
Acute Study Demonstrates Safety Of Vertos Medical’s Mild(R) Procedure; Findings Appear In Pain Physician Journal (Medical News Today)

Medical device company Vertos Medical Inc. has reported that an observational study on mild, published in the January/February 2010 issue of the peer-reviewed journal Pain Physician, has demonstrated the acute safety of the procedure in the treatment of lumbar spinal stenosis (LSS).

The rest is here:
Observational study on mild demonstrates acute safety of procedure in treatment of LSS (News-Medical-Net)

Medical device company Vertos Medical Inc. has reported that an observational study on mild, published in the January/February 2010 issue of the peer-reviewed journal Pain Physician, has demonstrated the acute safety of the procedure in the treatment of lumbar spinal stenosis (LSS).

Continue reading here:
Observational study on mild demonstrates acute safety of procedure in treatment of LSS

Medical device company Vertos Medical Inc. has reported that an observational study on mild, published in the January/February 2010 issue of the peer-reviewed journal Pain Physician, has demonstrated the acute safety of the procedure in the treatment of lumbar spinal stenosis (LSS).

Visit link:
Observational study on mild demonstrates acute safety of procedure in treatment of LSS

ALISO VIEJO, Calif.—-Medical device company Vertos Medical Inc. has announced the completion of enrollment in its post-market U.S. IRB I Patient Outcomes Trial, a 75-patient study of the mild* procedure.

Go here to see the original:
Vertos Medical Completes Enrollment in U.S. IRB I Study of mild®, Unveils Comprehensive Clinical Strategy (Business Wire via Yahoo! Finance)

Medical device company Vertos Medical, Inc., developer of the mild® procedure for lumbar spinal stenosis (LSS), today announced it has completed a $15.5 million Series D financing.

Read this article:
Vertos Medical raises $15.5 million for U.S. commercialization of the company’s "mild" technology